Giampaolo Trivellin
gp83.bsky.social
Giampaolo Trivellin
@gp83.bsky.social
Assistant Professor @ Humanitas University in Milan 🇮🇹. UniPD 🇮🇹, QMUL 🇬🇧, NIH 🇺🇸, Marie Curie 🇪🇺 alumnus. EYRC (@eyrc.bsky.social) coordinator 🇪🇺. Views are my own
Reposted by Giampaolo Trivellin
What a kickoff! 🎉 Day 1️⃣ of #EYES2025 in Milan was buzzing with energy, ideas, and networking.

🌟 Inspiring plenary lecture by Prof. Stratakis
🤝 Lively joint session with EYRC
🧪 Brilliant talks & posters from our ECIs
Day 2️⃣ — we’re ready! 🌱
@esendocrinology.bsky.social @ksaravinovska.bsky.social
September 27, 2025 at 2:04 PM
Reposted by Giampaolo Trivellin
Dont miss the EYRC Session at the ENEA Workshop 2025 | Marseille, France 🇫🇷

Workshop Dates: 3–5 December 2025
More on LinkedIn: @enea-young-researcher-committee
August 22, 2025 at 12:20 PM
Reposted by Giampaolo Trivellin
📢 Call for Abstracts – #ENEAWorkshop2025 🇫🇷
📅 3–5 Dec | Marseille
Theme: Changing the Paradigms – Translational Approach in Pituitary Tumors

📌 Deadline: 15 Sept 2025
✍️ Max 300 words | <41y = YIA eligible
📩 [email protected]

🔗 lnkd.in/e4yUiGZ9
September 9, 2025 at 7:51 AM
Reposted by Giampaolo Trivellin
🥳 Happy to share the results of an ongoing work in which we are applying POSTRE (our tool for SV interpretation github.com/vicsanga/Pos...) to better comprehend the cause of X-LAG tumors, a pituitary disorder responsible for an overgrowth condition 🧬. Preprint: www.medrxiv.org/content/10.1...
1/3
Distinguishing benign from pathogenic duplications involving GPR101 and VGLL1-adjacent enhancers in the clinical setting with the bioinformatic tool POSTRE
Background Structural variants (SVs) that disrupt topologically associating domains (TADs) can cause disease by rewiring enhancer-promoter interactions. Duplications involving GPR101 are known to caus...
www.medrxiv.org
July 10, 2025 at 10:11 PM
Reposted by Giampaolo Trivellin
🧵1/3
Our new preprint is out! Proud to have contributed to this collaborative study. We identified the enhancer cluster responsible for GPR101 overexpression in X-linked acrogigantism (X-LAG) - a key step toward understanding this rare pituitary disorder 🧠🧬
🔗 www.medrxiv.org/content/10.1...
Distinguishing benign from pathogenic duplications involving GPR101 and VGLL1-adjacent enhancers in the clinical setting with the bioinformatic tool POSTRE
Background Structural variants (SVs) that disrupt topologically associating domains (TADs) can cause disease by rewiring enhancer-promoter interactions. Duplications involving GPR101 are known to caus...
www.medrxiv.org
July 9, 2025 at 1:47 PM
Reposted by Giampaolo Trivellin
📣 Thrilled to announce our next speaker for the EYES Annual Meeting in Milan – Prof. Constantine Stratakis!

💡 Register & submit your abstract! ⏳

🇮🇹 Join us in Milan!

@esendocrinology.bsky.social @ksaravinovska.bsky.social
June 9, 2025 at 2:35 PM
Reposted by Giampaolo Trivellin
Delighted & excited to share our latest preprint on non-canonical enhancers in human pluripotent stem cells, the result of a fantastic and fun collaboration with @guenesdoganlab.bsky.social‬:
www.biorxiv.org/content/10.1...

🧵 below
Non-canonical enhancers control gene expression and cell fate in human pluripotent stem cells
Enhancers are key gene regulatory elements that ensure the precise spatiotemporal execution of developmental gene expression programmes. However recent findings indicate that approaches to identify en...
www.biorxiv.org
June 2, 2025 at 11:26 PM
Reposted by Giampaolo Trivellin
High prevalence of deleterious germline variants in cancer risk genes among subjects with young-onset, sporadic pituitary macroadenomas https://www.medrxiv.org/content/10.1101/2025.05.15.25327006v1
May 17, 2025 at 12:57 AM
Reposted by Giampaolo Trivellin
🚨 New Neuroendo Watch by EYRC – Highlight Alert! 🚨

We spotlight a study revealing how cholesterol metabolism drives dopamine agonist resistance in prolactinomas. 🧪🧠

Full post with takeaways on our LinkedIn page:
www.linkedin.com/company/enea-young-researcher-committee
May 6, 2025 at 4:26 PM
Reposted by Giampaolo Trivellin
The Oldest University In Every Country In The World

brilliantmaps.com/oldest-un...
April 7, 2025 at 5:01 PM
Reposted by Giampaolo Trivellin
THREAD

The numbers are in. @bsky.app research sharing volumes vs X Formerly Twitter

In March 2024, on most days, Bluesky hosts more posts linked to research published in 2025 than X.

By quite a lot.

Release the Kraken...

#AcademicSky #HigherEd #Altmetrics
1/11
March 27, 2025 at 5:22 PM
Reposted by Giampaolo Trivellin
🚀 EYRC Neuroendo Watch

We highlight a study in Endocrine, offering new insights into MEN5: tinyurl.com/25n94ac3

📌First reported case of pit-gigantism linked to a germline MAX mutation
📌Myelolipoma as a new disease association in MEN5
📌Expansion of the phenotype beyond PPGLs

By @gp83.bsky.social
March 10, 2025 at 3:53 PM
Reposted by Giampaolo Trivellin
Welcome to the ENEA Young Researchers Committee (EYRC), a subcommittee of ENEA dedicated to supporting early career scientists in neuroendocrinology.

✨ Our Mission:
🔹 Strengthening ENEA’s visibility
🔹 Representing early career researchers
🔹 Organizing symposia & workshops
🔹 And much more ...
February 16, 2025 at 4:12 PM
When your weekend’s pancake turns out to look something like a #zebrafish embryo during the gastrula period 🤣
@zebrafishrock.bsky.social
February 3, 2025 at 9:57 PM
Reposted by Giampaolo Trivellin
Did you know 2024 was our 20th anniversary? We're closing it out by sharing a brief history of Addgene, with commentary from our incredible community.
Read it below!

blog.addgene.org/add...
Addgene: The First Twenty Years
Twenty years have gone by fast! Join us to share some highlights of Addgene and our community as we close out our 20th anniversary celebration.
blog.addgene.org
December 31, 2024 at 8:02 PM
Density Gradient Centrifugation!
December 21, 2024 at 7:35 PM